Research ExplorerPublicationsFive plus three for the pancreas

Five plus three for the pancreas

Standard

Five plus three for the pancreas. / Löhr, J-Matthias; Pantel, Klaus.

In: CLIN CANCER RES, Vol. 29, No. 8, 14.04.2023, p. 1387-1389.

Research output: SCORING: Contribution to journal › Editorial › Research

Harvard

Löhr, J-M & Pantel, K 2023, 'Five plus three for the pancreas', CLIN CANCER RES, vol. 29, no. 8, pp. 1387-1389. https://doi.org/10.1158/1078-0432.CCR-22-3977

APA

Löhr, J-M., & Pantel, K. (2023). Five plus three for the pancreas. CLIN CANCER RES, 29(8), 1387-1389. https://doi.org/10.1158/1078-0432.CCR-22-3977

Vancouver

Löhr J-M, Pantel K. Five plus three for the pancreas. CLIN CANCER RES. 2023 Apr 14;29(8):1387-1389. https://doi.org/10.1158/1078-0432.CCR-22-3977

Bibtex

@article{6d90cbc9eb294bac83ac0c1b8369550e,
title = "Five plus three for the pancreas",
abstract = "Preneoplastic high-risk lesions in the pancreas need to be differentiated from low-risk lesions warranting surveillance and eventually surgical intervention. Imaging is used so far; however, certain imaging features are subject to interpretation and hence have their intrinsic flaws. In a recent article, a liquid biopsy with protein and RNA markers demonstrates differentiation based on a blood test. See related article by Zhang et al., p. 1535.",
author = "J-Matthias L{\"o}hr and Klaus Pantel",
year = "2023",
month = apr,
day = "14",
doi = "10.1158/1078-0432.CCR-22-3977",
language = "English",
volume = "29",
pages = "1387--1389",
journal = "CLIN CANCER RES",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

RIS

TY - JOUR

T1 - Five plus three for the pancreas

AU - Löhr, J-Matthias

AU - Pantel, Klaus

PY - 2023/4/14

Y1 - 2023/4/14

N2 - Preneoplastic high-risk lesions in the pancreas need to be differentiated from low-risk lesions warranting surveillance and eventually surgical intervention. Imaging is used so far; however, certain imaging features are subject to interpretation and hence have their intrinsic flaws. In a recent article, a liquid biopsy with protein and RNA markers demonstrates differentiation based on a blood test. See related article by Zhang et al., p. 1535.

AB - Preneoplastic high-risk lesions in the pancreas need to be differentiated from low-risk lesions warranting surveillance and eventually surgical intervention. Imaging is used so far; however, certain imaging features are subject to interpretation and hence have their intrinsic flaws. In a recent article, a liquid biopsy with protein and RNA markers demonstrates differentiation based on a blood test. See related article by Zhang et al., p. 1535.

U2 - 10.1158/1078-0432.CCR-22-3977

DO - 10.1158/1078-0432.CCR-22-3977

M3 - Editorial

C2 - 36719761

VL - 29

SP - 1387

EP - 1389

JO - CLIN CANCER RES

JF - CLIN CANCER RES

SN - 1078-0432

IS - 8

ER -